APOBEC3G and G-to-A hypermutation in Asian children with different HIV/AIDS disease progression

(78.0%) could correctly statehowACTcouldbeused inmanagement malaria in children under five. Conclusion:Due to high level of unacceptability and affordability ACT adoption for management of malaria in children less than five years is still at startling level among their mothers. However, ACT drugs should be made acceptable, affordable and available by government and partners in management of malaria among children in Africa.